576 related articles for article (PubMed ID: 17098277)
1. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
3. Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex.
Carrier M; Rodger MA; Fergusson D; Doucette S; Kovacs MJ; Moore J; Kelton JG; Knoll GA
Kidney Int; 2008 Jan; 73(2):213-9. PubMed ID: 17943076
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin.
Adiguzel C; Bansal V; Litinas E; Cunanan J; Iqbal O; Nelson K; Kannan M; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2009; 15(2):145-51. PubMed ID: 19357103
[TBL] [Abstract][Full Text] [Related]
5. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
[TBL] [Abstract][Full Text] [Related]
6. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
8. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
Lo GK; Sigouin CS; Warkentin TE
Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
[TBL] [Abstract][Full Text] [Related]
9. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies.
Morel-Kopp MC; Aboud M; Tan CW; Kulathilake C; Ward C
Thromb Res; 2010 May; 125(5):e234-9. PubMed ID: 20053425
[TBL] [Abstract][Full Text] [Related]
10. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R
Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
Look KA; Sahud M; Flaherty S; Zehnder JL
Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
Matsuo T; Wanaka K; Walenga JM
Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
16. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.
Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C
Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of the prevalence of heparin-induced antibodies and other associated thromboembolic risk factors in pediatric patients undergoing hemodialysis.
Skouri H; Gandouz R; Abroug S; Kraiem I; Euch H; Gargouri J; Harbi A
Am J Hematol; 2006 May; 81(5):328-34. PubMed ID: 16628723
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.
Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H
Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with positive heparin-platelet factor-4 antibodies: A retrospective multi-institutional observational study.
Tapan U; Bolla S; Daglilar ES; Chang S; Kozyreva O
Platelets; 2015; 26(7):661-4. PubMed ID: 25383658
[TBL] [Abstract][Full Text] [Related]
20. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
